119 related articles for article (PubMed ID: 31741771)
21. Patient-derived cancer models: Valuable platforms for anticancer drug testing.
Genta S; Coburn B; Cescon DW; Spreafico A
Front Oncol; 2022; 12():976065. PubMed ID: 36033445
[TBL] [Abstract][Full Text] [Related]
22. Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice.
Szulzewsky F; Arora S; Arakaki AKS; Sievers P; Almiron Bonnin DA; Paddison PJ; Sahm F; Cimino PJ; Gujral TS; Holland EC
Genes Dev; 2022 Aug; 36(13-14):857-70. PubMed ID: 36008139
[TBL] [Abstract][Full Text] [Related]
23.
Moya-Garcia CR; Okuyama H; Sadeghi N; Li J; Tabrizian M; Li-Jessen NYK
Front Oncol; 2022; 12():960340. PubMed ID: 35992863
[TBL] [Abstract][Full Text] [Related]
24. Precision-Cut Tumor Slices (PCTS) as an Ex Vivo Model in Immunotherapy Research.
Dimou P; Trivedi S; Liousia M; D'Souza RR; Klampatsa A
Antibodies (Basel); 2022 Apr; 11(2):. PubMed ID: 35466279
[TBL] [Abstract][Full Text] [Related]
25. Proteomic and Transcriptomic Profiling Reveals Mitochondrial Oxidative Phosphorylation as Therapeutic Vulnerability in Androgen Receptor Pathway Active Prostate Tumors.
Xue C; Corey E; Gujral TS
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406510
[TBL] [Abstract][Full Text] [Related]
26. Novel
Clark J; Fotopoulou C; Cunnea P; Krell J
Front Oncol; 2022; 12():837233. PubMed ID: 35402223
[TBL] [Abstract][Full Text] [Related]
27. Patient-Derived In Vitro and In Vivo Models of Cancer.
Claridge SE; Cavallo JA; Hopkins BD
Adv Exp Med Biol; 2022; 1361():215-233. PubMed ID: 35230691
[TBL] [Abstract][Full Text] [Related]
28. The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies.
Berg AL; Rowson-Hodel A; Hu M; Keeling M; Wu H; VanderVorst K; Chen JJ; Hatakeyama J; Jilek J; Dreyer CA; Wheeler MR; Yu AM; Li Y; Carraway KL
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205696
[TBL] [Abstract][Full Text] [Related]
29. Polypharmacologic Reprogramming of Tumor-Associated Macrophages toward an Inflammatory Phenotype.
Nishida-Aoki N; Gujral TS
Cancer Res; 2022 Feb; 82(3):433-446. PubMed ID: 34903600
[TBL] [Abstract][Full Text] [Related]
30. Interplay between Cellular and Non-Cellular Components of the Tumour Microenvironment in Hepatocellular Carcinoma.
Sükei T; Palma E; Urbani L
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771746
[TBL] [Abstract][Full Text] [Related]
31. Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers.
Arakaki AKS; Szulzewsky F; Gilbert MR; Gujral TS; Holland EC
Neuro Oncol; 2021 Nov; 23(23 Suppl 5):S4-S15. PubMed ID: 34725698
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Chemotherapy Drug Response Using Organotypic Cultures of Osteosarcoma Tumours from Mice Models and Canine Patients.
Brulin B; Nolan JC; Marangon T; Kovacevic M; Chatelais M; Meheust P; Abadie J; Le Nail LR; Rosset P; Brennan MÁ; Layrolle P
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638373
[TBL] [Abstract][Full Text] [Related]
33. Computational modeling identifies multitargeted kinase inhibitors as effective therapies for metastatic, castration-resistant prostate cancer.
Bello T; Paindelli C; Diaz-Gomez LA; Melchiorri A; Mikos AG; Nelson PS; Dondossola E; Gujral TS
Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34593636
[TBL] [Abstract][Full Text] [Related]
34. Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy.
Lei JH; Lee MH; Miao K; Huang Z; Yao Z; Zhang A; Xu J; Zhao M; Huang Z; Zhang X; Chen S; Jiaying NG; Feng Y; Xing F; Chen P; Sun H; Chen Q; Xiang T; Chen L; Xu X; Deng CX
Adv Sci (Weinh); 2021 Nov; 8(21):e2100974. PubMed ID: 34514747
[TBL] [Abstract][Full Text] [Related]
35. PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinoma.
Hußtegge M; Hoang NA; Rebstock J; Monecke A; Gockel I; Weimann A; Schumacher G; Bechmann I; Lordick F; Kallendrusch S; Körfer J
Oncoimmunology; 2021; 10(1):1960729. PubMed ID: 34434611
[TBL] [Abstract][Full Text] [Related]
36. Protocol for tissue slice cultures from human solid tumors to study therapeutic response.
Kenerson HL; Sullivan KM; Labadie KP; Pillarisetty VG; Yeung RS
STAR Protoc; 2021 Jun; 2(2):100574. PubMed ID: 34142099
[TBL] [Abstract][Full Text] [Related]
37. Engineered in vitro tumor models for cell-based immunotherapy.
Ando Y; Mariano C; Shen K
Acta Biomater; 2021 Sep; 132():345-359. PubMed ID: 33857692
[TBL] [Abstract][Full Text] [Related]
38. Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma.
Afanasyeva EA; Gartlgruber M; Ryl T; Decaesteker B; Denecker G; Mönke G; Toprak UH; Florez A; Torkov A; Dreidax D; Herrmann C; Okonechnikov K; Ek S; Sharma AK; Sagulenko V; Speleman F; Henrich KO; Westermann F
Life Sci Alliance; 2021 May; 4(5):. PubMed ID: 33658318
[TBL] [Abstract][Full Text] [Related]
39. A Miniaturized Platform for Multiplexed Drug Response Imaging in Live Tumors.
Bhagavatula S; Thompson D; Ahn SW; Upadhyaya K; Lammers A; Deans K; Dominas C; Ferland B; Valvo V; Liu G; Jonas O
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562152
[TBL] [Abstract][Full Text] [Related]
40. Polymer-loaded hydrogels serve as depots for lactate and mimic "cold" tumor microenvironments.
Allen R; Ivtchenko E; Thuamsang B; Sangsuwan R; Lewis JS
Biomater Sci; 2020 Nov; 8(21):6056-6068. PubMed ID: 33000781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
